MétaCan
Menu
← Back to cohort
Record W3151577537 · doi:10.1016/j.jtct.2021.03.028

Breaking the Age Barrier: Physicians’ Perceptions of Candidacy for Allogeneic Hematopoietic Cell Transplantation in Older Adults

2021· article· en· W3151577537 on OpenAlexaff
Asmita Mishra, Jaime M. Preussler, Vijaya Raj Bhatt, Christopher Bredeson, Saurabh Chhabra, Anita D’Souza, Parastoo B. Dahi, Eileen Danaher Hacker, Lohith Gowda, Shahrukh K. Hashmi, Dianna S. Howard, Ann A. Jakubowski, Reena Jayani, Thuy T. Koll, Richard J. Lin, Rebecca L. Olin, Uday Popat, Cesar Rodriguez, Ashley Rosko, Mitchell Sabloff, Mohamed L. Sorror, Anthony D. Sung, Celalettin Üstün, William A. Wood, Linda J. Burns, Andrew Artz

Bibliographic record

VenueTransplantation and Cellular Therapy · 2021
Typearticle
Languageen
FieldMedicine
TopicPalliative Care and End-of-Life Issues
Canadian institutionsOttawa Hospital
FundersJanssen PharmaceuticalsNational Center for Advancing Translational SciencesAbbott LaboratoriesNational Institute on AgingU.S. Public Health ServiceGenentechDaiichi-SankyoKyowa Kirin Pharmaceutical DevelopmentNational Institute of Allergy and Infectious DiseasesAngiocrine BioscienceMedical College of WisconsinNovartisMerckGlaxoSmithKlineTakeda Pharmaceuticals U.S.A.AmgenNational Heart, Lung, and Blood InstitutePfizerHealth Resources and Services AdministrationAstellas Pharma USOffice of Naval ResearchJazz PharmaceuticalsIntel CorporationNational Cancer InstituteAbbVieSanofi
KeywordsCandidacyMedicineHematopoietic cellTransplantationYoung adultRegimenFamily medicineGerontologyInternal medicineStem cellHaematopoiesis

Abstract

fetched live from OpenAlex

Despite continuing increases in the use of allogeneic hematopoietic cell transplantation (alloHCT) in older adults, no standardized geriatric assessment (GA) has been established to risk stratify for transplantation-related morbidity. We conducted a survey of transplant physicians to determine perceptions of the impact of older age (≥60 years) on alloHCT candidacy, and utilization of tools to gauge candidacy. This 23-item online cross-sectional survey was distributed to HCT physicians caring for adults in the United States between May and July 2019. Of the 770 invited HCT physicians, 175 (22.7%) completed the survey. The majority of respondents were age 41 to 60 years and male and practiced in a higher-volume teaching hospital. When considering regimen intensity, 29 physicians (17%) stated they would consider a myeloablative regimen for patients age ≥70 years, and 141 (82%) would consider reduced-intensity/nonmyeloablative conditioning for patients age ≥70 years. Almost all (90%) endorsed the need for a specialized assessment of pre-HCT vulnerabilities to guide candidacy decisions for older adults. Most physicians reported that their centers rarely (33%) or never (46%) use a dedicated geriatrician/geriatric-oncologist to assess alloHCT candidates age ≥60 years. Common barriers to performing a GA included uncertainty about which tools to use, lack of knowledge and training, and lack of appropriate clinical support staff. Many alloHCT physicians will consider alloHCT in patients up to age 75 years and not uncommonly in patients older than that. However, the application of tools and domains to assess candidacy in older adults varies widely. Incorporation of a standardized pretransplantation health assessment tool for risk stratification is a significant unmet need.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.006
metaresearch head score (Gemma)0.033
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.015
Threshold uncertainty score0.033

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0060.033
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.000
Science and technology studies0.0030.002
Scholarly communication0.0030.002
Open science0.0000.002
Research integrity0.0020.003
Insufficient payload (model declined to judge)0.0040.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.032
GPT teacher head0.325
Teacher spread0.293 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations32
Published2021
Admission routes1
Has abstractno

Explore more

Same venueTransplantation and Cellular Therapy→Same topicPalliative Care and End-of-Life Issues→French-language works237,207→